Literature DB >> 24964907

The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa.

Huseyin Agah Terzi1, Canan Kulah, Ihsan Hakkı Ciftci.   

Abstract

In this study, we investigated the roles of active efflux pumps in antibiotic resistance. The transcription efflux pump genes were analyzed by real-time polymerase chain reaction (qPCR) to determine their role in drug resistance. Antibiotic sensitivity testing was carried out using the Vitek 2 automated system (bioMérieux, France). Isolates were divided into four groups according to their resistance status: multiple-drug resistant (MDR), isolated carbapenem resistant (ICR), isolated quinolone resistant (IQR), and carbapenem and quinolone resistant (CQR). Transcript levels of mexB, mexD, mexF, and mexY were analyzed by qPCR using a LightCycler instrument (Roche, Germany). The genetic similarity between isolates was determined using arbitrarily primed PCR (AP-PCR). Among the 50 isolates investigated, the frequency of genes classified as overexpressed were 88 % for mexD, 76 % for mexB, 46 % for mexF, and 40 % for mexY. Within the MDR group, mexB was overexpressed in 15 of 22 isolates, mexD in 20 of 22, mexF in 15 of 22, and mexY in 19 of 22. In the ICR group, isolates mexB and mexD were each overexpressed in five isolates. mexD overexpression was observed in all seven CQR isolates. Within the IQR group, mexB and mexD were overexpressed in all 12 isolates. mexF overexpression was detected in 7 of 12 isolates in this group. 18 distinct banding patterns were determined by AP-PCR. Increased transcription of mexB was directly correlated with meropenem resistance in the majority of isolates tested, while MexCD-OprJ and MexEF-OprN were related to quinolone resistance; the MexCD-OprJ efflux pump was also related to multidrug resistance. Increased transcription of mexY may contribute to the gentamicin resistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24964907     DOI: 10.1007/s11274-014-1692-2

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  25 in total

1.  Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa.

Authors:  T Köhler; M Michéa-Hamzehpour; U Henze; N Gotoh; L K Curty; J C Pechère
Journal:  Mol Microbiol       Date:  1997-01       Impact factor: 3.501

Review 2.  Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

Authors:  John E McGowan
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

3.  Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  Didier Hocquet; Patrice Nordmann; Farid El Garch; Ludovic Cabanne; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; Fe Tubau; María D Macia; Cristina Rodríguez; Bartolomé Moya; Laura Zamorano; Cristina Suárez; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

5.  Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa.

Authors:  X Z Li; L Zhang; R Srikumar; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation.

Authors:  B Henrichfreise; I Wiegand; W Pfister; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

7.  Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil.

Authors:  Danilo E Xavier; Renata C Picão; Raquel Girardello; Lorena C C Fehlberg; Ana C Gales
Journal:  BMC Microbiol       Date:  2010-08-12       Impact factor: 3.605

Review 8.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

9.  Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa.

Authors:  Christian G Giske; Liselotte Buarø; Arnfinn Sundsfjord; Bengt Wretlind
Journal:  Microb Drug Resist       Date:  2008-03       Impact factor: 3.431

Review 10.  Pseudomonas aeruginosa - a phenomenon of bacterial resistance.

Authors:  Tanya Strateva; Daniel Yordanov
Journal:  J Med Microbiol       Date:  2009-06-15       Impact factor: 2.472

View more
  10 in total

1.  Novel Aminoglycoside-Tolerant Phoenix Colony Variants of Pseudomonas aeruginosa.

Authors:  Devin Sindeldecker; Kelly Moore; Anthony Li; Daniel J Wozniak; Matthew Anderson; Devendra H Dusane; Paul Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  Two Regulators, PA3898 and PA2100, Modulate the Pseudomonas aeruginosa Multidrug Resistance MexAB-OprM and EmrAB Efflux Pumps and Biofilm Formation.

Authors:  Yun Heacock-Kang; Zhenxin Sun; Jan Zarzycki-Siek; Kanchana Poonsuk; Ian A McMillan; Rungtip Chuanchuen; Tung T Hoang
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

3.  Dynamics of Intact MexAB-OprM Efflux Pump: Focusing on the MexA-OprM Interface.

Authors:  Cesar A López; Timothy Travers; Klaas M Pos; Helen I Zgurskaya; S Gnanakaran
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

4.  History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment.

Authors:  Phillip Yen; Jason A Papin
Journal:  PLoS Biol       Date:  2017-08-08       Impact factor: 8.029

5.  Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.

Authors:  Ping Yang; Yunbo Chen; Saiping Jiang; Ping Shen; Xiaoyang Lu; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-19       Impact factor: 4.887

6.  Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of Escherichia coli.

Authors:  Alessio Atzori; Giuliano Malloci; Francesca Cardamone; Andrea Bosin; Attilio Vittorio Vargiu; Paolo Ruggerone
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

7.  Comparative genome analysis of multidrug-resistant Pseudomonas aeruginosa JNQH-PA57, a clinically isolated mucoid strain with comprehensive carbapenem resistance mechanisms.

Authors:  Mingju Hao; Wanshan Ma; Xiutao Dong; Xiaofeng Li; Fang Cheng; Yujiao Wang
Journal:  BMC Microbiol       Date:  2021-05-01       Impact factor: 3.605

8.  Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates.

Authors:  Huseyin-Agah Terzi; Ali-Rıza Atasoy; Sadiye-Berna Aykan; Engin Karakece; Gulsah Asık; Ihsan-Hakkı Ciftci
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

9.  Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems.

Authors:  Héctor Rudilla; Ester Fusté; Yolanda Cajal; Francesc Rabanal; Teresa Vinuesa; Miguel Viñas
Journal:  Molecules       Date:  2016-09-12       Impact factor: 4.411

10.  Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.

Authors:  Lei Zhao; Shiqi Wang; Xiaobing Li; Xiaojing He; Lingyan Jian
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-05       Impact factor: 4.887

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.